"Cryo-vacc talking to two companies in the medical sector. with r&d and finance capabilities so ideal partner(s) potentially. Let's not forget in a previous interview it was mentioned having 15,000 cryo-vacc units in circulation could be just as profitable as Phase 2 which is projected to be about AUD$500m per year of Ebitda. So maybe that ebitda has a chance to increase or even double if the cryo-vacc goes anywhere."
Comments I made in a post April 11 about a webinar done at the time. So maybe something will come of potential partnerships in the medical sector with the cryo-vacc
RLT CHART, page-3115
Add RLT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
79.0¢ |
Change
0.045(6.04%) |
Mkt cap ! $23.95M | |||
| Open | High | Low | Value | Volume |
| 75.5¢ | 79.5¢ | 75.5¢ | $2.398K | 3.075K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4285 | 73.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 85.5¢ | 11090 | 1 |
View Market Depth
| Last trade - 15.32pm 19/11/2024 (20 minute delay) ? |
| RLT (ASX) Chart |